- CVS Health Corp CVS is piloting a system, enabling pharmacists to process prescriptions in part remotely, in order to tackle the shortage of pharmacists.
- The move, the WSJ reported, would enhance store working conditions and customer experience.
- The technology equips pharmacists to asses and enter prescription information remotely without compromising patient privacy.
- CVS has implemented the technology in 8,000 of its more than 9,000 U.S. drugstores.
- About 400 of CVS's 30,000 pharmacists are engaged in preparing prescriptions at central locations, from their homes or in remote stores.
- The initiative will reduce the store pharmacists' workload, providing them time to offer services, including vaccinations and health screenings.
- "It's really a way to make the processing of prescriptions much more efficient," the report quoted CEO Karen Lynch.
- However, some practitioners have raised concerns about the plan's success amid chronic short staffing.
- The scope of CVS's rollout is limited in part by state regulations that require drugstores to have a certain number pharmacists on site or prohibit remote drug verification.
- CVS rival Walgreens Boots Alliance WBA said the shortage of pharmacists and technicians had affected its revenue.
- Price Action: CVS shares are trading higher by 0.06% at $102.64 in premarket on the last check Monday.
- Photo Via Company
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in